Correlation Between Ventyx Biosciences and Cingulate Warrants
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Cingulate Warrants, you can compare the effects of market volatilities on Ventyx Biosciences and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Cingulate Warrants.
Diversification Opportunities for Ventyx Biosciences and Cingulate Warrants
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ventyx and Cingulate is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Cingulate Warrants go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Cingulate Warrants
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Cingulate Warrants. But the stock apears to be less risky and, when comparing its historical volatility, Ventyx Biosciences is 13.71 times less risky than Cingulate Warrants. The stock trades about -0.03 of its potential returns per unit of risk. The Cingulate Warrants is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 24.00 in Cingulate Warrants on November 2, 2024 and sell it today you would lose (18.80) from holding Cingulate Warrants or give up 78.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 78.14% |
| Values | Daily Returns |
Ventyx Biosciences vs. Cingulate Warrants
Performance |
| Timeline |
| Ventyx Biosciences |
| Cingulate Warrants |
Ventyx Biosciences and Cingulate Warrants Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Cingulate Warrants
The main advantage of trading using opposite Ventyx Biosciences and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |